Sagimet Biosciences (SGMT) Shares Outstanding (2022 - 2026)
Sagimet Biosciences (SGMT) recorded quarterly Shares Outstanding of $567494.0 in Q1 2026, down 98.22% quarter-over-quarter from $32.0 million in Q4 2025, and down 98.15% on a YoY basis from $30.7 million in Q1 2025.
Sagimet Biosciences (SGMT) Shares Outstanding (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Shares Outstanding history runs 5 years deep, the most recent figure standing at $567494.0 for Q1 2026.
- In Q1 2026, Shares Outstanding fell 98.15% year-over-year to $567494.0; the TTM figure through Mar 2026 stood at $567494.0 (down 98.15% YoY), while the FY2025 annual figure was $32.0 million, up 4.17% from the prior year.
- Shares Outstanding was $567494.0 for Q1 2026 at Sagimet Biosciences, down from $32.0 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $32.0 million in Q1 2026 to a low of $185084.0 in Q2 2022.
- Historically, Shares Outstanding has averaged $14.7 million across 5 years, with a median of $11.4 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding surged 16321.41% in 2024, then sank 98.15% in 2026.
- A 5-year view of Shares Outstanding shows it stood at $185084.0 in 2022, then soared by 11449.03% to $21.4 million in 2023, then surged by 43.51% to $30.7 million in 2024, then advanced by 4.17% to $32.0 million in 2025, then sank by 98.22% to $567494.0 in 2026.
- The last three Shares Outstanding figures came in at $567494.0 (Q1 2026), $32.0 million (Q4 2025), and $31.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Sagimet Biosciences | 211.96 Mn | 211.96 Mn | - | 567,494.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 567,494.00 |
| Mar 31, 2026 | 32.02 Mn |
| Mar 31, 2026 | 32.02 Mn |
| Mar 31, 2026 | 32.02 Mn |
| Mar 31, 2026 | 567,494.00 |
| Mar 31, 2026 | 567,494.00 |
| Mar 31, 2026 | 567,494.00 |
| Mar 31, 2026 | 32.02 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Dec 31, 2025 | 31.95 Mn |
| Sep 30, 2025 | 31.00 Mn |
| Sep 30, 2025 | 31.00 Mn |
| Sep 30, 2025 | 31.00 Mn |
| Sep 30, 2025 | 31.00 Mn |